Efficacy can be low but safety should not be compromised: Bharat Biotech chief : News Reel: Business Today
Business Today
Loading...
 

Efficacy can be low but safety should not be compromised: Bharat Biotech chief

Rajeev Dubey | January 6, 2021

Dr Krishna Ella, Chairman of Bharat Biotech, said that unlike the clinical trials of AstraZeneca vaccine (which has been licensed to Serum Institute of India), Bharat Biotech did not try to suppress the side effects of vaccine by giving paracetamol to the volunteers. He also said that for his company safety came first. Watch him in conversation with Rajeev Dubey, Editor, Business Today.

Also Read: China denies entry to WHO team investigating COVID-19 origins



    More from this section
    09:02
    We will see more people migrating to Signal from WhatsApp: Aruna Harder
    16:46
    Experts discuss ways by which govt could spur growth of the economy
    03:13
    Turnout dips on day 3 of vaccination; Jobs in Japan for Indians
    10:39
    Covid cess or tax deduction? What Budget 2021 has in store for taxpayers
    04:07
    There has been a shift from quantity to quality education: Rajiv Kumar
    03:03
    Wipro completes share buyback; Parl panel summons FB, Twitter
    03:03
    Farmers firm on tractor rally, get ready for 10th round of talks
    29:10
    India's first vaccine shot administered to sanitation worker at AIIMS
    02:40
    MacBook Pro 2021 to feature MagSafe, M1 chips; Shaw chosen as USIBC Vice Chair
    05:09
    DFI Blueprint for financing infrastructure
    02:29
    Biden announces $1.9 trillion stimulus; Passenger vehicle sales surge in Dec
    02:41
    Countdown begins for COVID vaccination , PM to inaugurate
    02:47
    PC sales surge in 2020; Trump impeached over US Capitol siege
    04:48
    Major risks that can disrupt the stock rally, bring down the market
    07:40
    When will the market rally hit the 1 lakh mark?
    03:04
    Tesla sets up company in Bengaluru; Trump denies responsibility for Capitol siege
    14:42
    First consignment of Covishield reaches Delhi, Chennai, Ahmedabad
    02:47
    COVID herd immunity unlikely in 2021, says WHO; Bird flu hits 10 states
    03:53
    Signal is most downloaded app as users ditch WhatsApp
    02:57
    China recovering fast, says IMF; TCS biggest gainer on Dalal Street
    04:52
    India well prepared for vaccine rollout: Dr Swaminathan
    05:09
    70% need anti-bodies to stop the virus: WHO's Swaminathan
    05:34
    12 months before full vaccine approval: WHO's Chief Scientist
    02:22
    Twitter suspends Trump's account; Brazilian Prez asks for vaccines
    02:01
    Woman fraudulently uses Ratan Tata's car number
    03:53
    Sunil Mittal on how the push-button phone began his romance with telecom
    03:53
    Bharat Biotech seeks approval from DCGI for nasal vaccine trials
    03:21
    Musk becomes world's richest person; Premji thanks Wipro employees
    03:13
    Indian Air Force to supply vaccines to remote areas
    02:11
    Who will get the COVID vaccine first? Dr Randeep Guleria answers
    03:00
    China blocks the WHO team; Pichai condemns attack at US Capitol
    21:06
    World shocked as Trump supporters storm US Capitol; 4 die, many injured
    04:39
    Snowfall in J&K, highways blocked as cold wave grips north India
    02:39
    Bharat Biotech chief Dr Ella on vaccine efficacy controversy
    06:47
    Bird flu scare grips India amid the ongoing coronavirus situation
    02:48
    First vaccine shot likely on Jan 13; Ella on COVID vaccine for children
    01:31
    We need a national task force on pandemics to plug gaps: Dr Ella
    01:39
    We don't want to use the pandemic to make money: Bharat Biotech CMD
    02:38
    Bharat Biotech's Krishna Ella on ways to beat the next pandemic
    01:53
    Children's Covid vaccine in 3-4 months: Bharat Biotech's Ella